financetom
Business
financetom
/
Business
/
Tesla issuing new recall for 9,100 Model X SUVs over trim issue
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tesla issuing new recall for 9,100 Model X SUVs over trim issue
Aug 21, 2024 4:02 PM

Aug 21 (Reuters) - Tesla has issued a recall

for about 9,100 Model X sports utility vehicles in the U.S. over

a trim on the roof that could separate, it said on Wednesday,

its second over the same issue since 2020.

Front and center roof cosmetic trim pieces may be adhered

without primer, and could separate from the vehicle creating a

road hazard and increasing the risk of a crash, the National

Highway Traffic Safety Administration said.

The recall covers 2016 model year Model X SUVs. Tesla said a

change in process had been made at the supplier in July 2016 to

prevent the issue in later models.

The company will test adhesion of the roof trim and reattach

the trim pieces as necessary at no cost to owners of the

vehicles.

Since 2022 Tesla has been studying reports of issues

involving vehicles that had undergone the recall remedy and

conducted aging tests, including heat and humidity, it said on

Wednesday.

It concluded the 2020 recall remedy was not robust enough to

detect cosmetic roof trim pieces that may detach due to lack of

primer.

Tesla said it is aware of about 170 reports and claims that

may be related to the issue, but said it has no reports of

crashes or injuries tied to the recall issues.

This marks a rare physical recall for the Austin,

Texas-based automaker, which usually fixes issues through

over-the-air software updates.

Tesla recalled nearly 2.6 million vehicles due to safety

concerns in the first six months of the year, only behind Ford

Motor which has recalled about 3.6 million vehicles in the U.S.,

according to recall management platform developer Bizzycar.

(Reporting by Akash Sriram in Bengaluru and David Shepardson;

Editing by Varun H K)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
FedEx Stock Jumps On Q1 Earnings Beat
FedEx Stock Jumps On Q1 Earnings Beat
Sep 20, 2025
FedEx Corp ( FDX ) delivered its financial results for the first quarter of fiscal 2026 on Thursday after the bell. Here’s a look at the key details from the report. FDX stock is racing ahead of the pack after-hours. Get the latest updates here. Q1 Highlights: FedEx ( FDX ) reported first-quarter revenue of $22.2 billion, beating analyst estimates of $21.67...
E.l.f. Beauty Insider Sold Shares Worth $1,147,385, According to a Recent SEC Filing
E.l.f. Beauty Insider Sold Shares Worth $1,147,385, According to a Recent SEC Filing
Sep 20, 2025
04:25 PM EDT, 09/18/2025 (MT Newswires) -- Joshua Allen Franks, Senior Vice President, Operations, on September 16, 2025, sold 7,913 shares in E.l.f. Beauty (ELF) for $1,147,385. Following the Form 4 filing with the SEC, Franks has control over a total of 99,369 common shares of the company, with 99,369 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1600033/000161071725000343/xslF345X05/form4.xml ...
BJ's Wholesale Club Holdings Insider Sold Shares Worth $629,118, According to a Recent SEC Filing
BJ's Wholesale Club Holdings Insider Sold Shares Worth $629,118, According to a Recent SEC Filing
Sep 20, 2025
04:25 PM EDT, 09/18/2025 (MT Newswires) -- Graham Luce, Executive Vice President, Secretary, on September 17, 2025, sold 6,300 shares in BJ's Wholesale Club Holdings (BJ) for $629,118. Following the Form 4 filing with the SEC, Luce has control over a total of 11,617 common shares of the company, with 11,617 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1531152/000153115225000114/xslF345X05/wk-form4_1758226650.xml ...
US FDA approves Incyte's eczema treatment for pediatric patients
US FDA approves Incyte's eczema treatment for pediatric patients
Sep 20, 2025
Sept 18 (Reuters) - The U.S. Food and Drug Administration has approved Incyte's ( INCY ) eczema treatment for children aged between 2 and 11 years, the company said on Thursday. It was previously approved for individuals aged 12 years and older. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved